Tamoxifen binding sites heterogeneity in breast cancer: a comparative study with steroid hormone receptors

This publication has 17 references indexed in Scilit:

• Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
  Science, 1988
• Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues
  Breast Cancer Research and Treatment, 1987
• New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen
  Biochemical and Biophysical Research Communications, 1986
• An Evaluation of the Role of Antiestrogen-Binding Sites in Mediating the Growth Modulatory Effects of Antiestrogens: Studies Usingt-Butylphenoxyethyl Diethylamine, a Compound Lacking Affinity for the Estrogen Receptor*
  Endocrinology, 1985
• The pharmacology and clinical uses of tamoxifen
  Pharmacology & Therapeutics, 1984
• Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
  European Journal of Cancer and Clinical Oncology, 1983
• Antiestrogen-Binding Sites Distinct from the Estrogen Receptor: Subcellular Localization, Ligand Specificity, and Distribution in Tissues of the Rat*
  Endocrinology, 1983
• High-affinity anti-oestrogen binding site distinct from the oestrogen receptor
  Nature, 1980
• Cytosol estradiol receptor in human mammary carcinoma: An assay based on isoelectric focusing in polyacrylamide gel
  Analytical Biochemistry, 1978
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
  Annals of the New York Academy of Sciences, 1949